Published in Electroencephalogr Clin Neurophysiol on March 01, 1974
Effects of supraphysiological doses of levothyroxine on sleep in healthy subjects: a prospective polysomnography study. J Thyroid Res (2011) 0.78
The neurophysiological aspects of sleep. Postgrad Med J (1976) 0.75
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
Five Weeks to Escape the Sleeping-pill Habit. Br Med J (1965) 4.99
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Human immunodeficiency virus integration in a cell-free system. J Virol (1990) 4.48
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Genetic control of natural variation in Arabidopsis glucosinolate accumulation. Plant Physiol (2001) 4.07
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93
Possible mechanism for adverse reactions to triazolam. Lancet (1991) 3.28
Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Bias inherent in retrospective waiting-time studies: experience from a vascular surgery waiting list. CMAJ (2000) 2.74
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
Anxiety caused by a short-life hypnotic. Br Med J (Clin Res Ed) (1982) 2.51
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Further evidence for small-bodied hominins from the Late Pleistocene of Flores, Indonesia. Nature (2005) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology (1987) 2.46
Anxiety and sleep after fosazepam. Br J Clin Pharmacol (1976) 2.42
An extremely luminous X-ray outburst at the birth of a supernova. Nature (2008) 2.41
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
New clinical sign for orthostatic tremor. Lancet (1995) 2.25
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett (2000) 2.22
Gastric cancer detection in gastric ulcer disease. Gut (1980) 2.20
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
Bovine spongiform encephalopathy [corrected] Creutzfeldt-Jakob disease. BMJ (1996) 2.15
Criminal patients with XYY sex-chromosome complement. Lancet (1966) 2.14
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol (1986) 2.06
Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med (1986) 2.06
Supervised harvesting of expression trees. Genome Biol (2001) 2.02
Fenfluramine overdosage. Lancet (1969) 2.01
Effects of two slimming drugs on sleep. Br Med J (1968) 2.01
Estimating cancer risk in relation to tritium exposure from routine operation of a nuclear-generating station in Pickering, Ontario. Chronic Dis Inj Can (2013) 1.97
Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors. Phys Med Biol (1971) 1.89
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Two anti-anxiety drugs: a psychoneuroendocrine study. Br Med J (1973) 1.86
Human brain protein, drugs and dreams. Nature (1969) 1.86
Chiropractic care of children with nocturnal enuresis: a prospective outcome study. J Manipulative Physiol Ther (1991) 1.85
Assessment of aggression in psychiatric admissions: semistructured interview and case note survey. BMJ (2000) 1.85
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
Phenelzine, mood response, and sleep. Arch Gen Psychiatry (1973) 1.82
Typing prion isoforms. Nature (1997) 1.82
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A (1999) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population. Ann Rheum Dis (1991) 1.79
Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia. Neuroscience (2006) 1.78
Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (2000) 1.77
Kofi Annan describes new health fund for developing countries. BMJ (2001) 1.76
Ionophore toxicity in turkey breeders. Avian Dis (1983) 1.76
Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med (1985) 1.75
Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord (1998) 1.74
Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol (1989) 1.74
Enhancement of calcium current in Aplysia neurones by phorbol ester and protein kinase C. Nature (1985) 1.73
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72
Familial pseudohyperkalaemia. A new syndrome. Lancet (1979) 1.71
Triazolam. Unpublished manufacturers research unfavourable. BMJ (1993) 1.70
A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology (1994) 1.70
Benzodiazepine hypnotics remain effective for 24 weeks. Br Med J (Clin Res Ed) (1982) 1.70
Improvement of stiff-man syndrome with vigabatrin. Neurology (1997) 1.68
Cancer registries fear imminent collapse. BMJ (2000) 1.68
Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science (1987) 1.67
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
Illusory perceptions of space and time preserve cross-saccadic perceptual continuity. Nature (2001) 1.64
[Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)]. Rev Neurol (Paris) (1978) 1.61
Updating the Read Codes: user-interactive maintenance of a dynamic clinical vocabulary. J Am Med Inform Assoc (1997) 1.60
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Scratching during sleep. Lancet (1973) 1.60
Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet (1994) 1.59
The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol Cell Biol (1991) 1.59
Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease. Neurology (2010) 1.58
Muscle force is generated by myosin heads stereospecifically attached to actin. Nature (1997) 1.56
Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet (1991) 1.56
A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt-Jakob disease. Neurology (1993) 1.55
EEG-EMG, MEG-EMG and EMG-EMG frequency analysis: physiological principles and clinical applications. Clin Neurophysiol (2002) 1.54
Drugs of dependence though not of abuse: fenfluramine and imipramine. Br Med J (1971) 1.50
UK death rates from breast cancer fall by a third. BMJ (2000) 1.50
Stimulation of protein kinase C recruits covert calcium channels in Aplysia bag cell neurons. Nature (1987) 1.50
Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med (1982) 1.48
Triazolam syndrome 10 years on. Lancet (1989) 1.48
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin Cancer Res (1998) 1.48
Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol (1991) 1.48
The use of relaxation for the promotion of comfort and pain relief in persons with advanced cancer. Contemp Nurse (1994) 1.47
Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br J Psychiatry (1972) 1.46
Reproducibility of the microdilution checkerboard method for antibiotic synergy. Antimicrob Agents Chemother (1993) 1.46